| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.4M | +442.3% |
| Cost of Revenue | $249K | +678.1% |
| R&D Expense | $1.1M | +74.4% |
| SG&A Expense | $14.3M | +448.5% |
| Operating Income | -$36.4M | -1111.9% |
| Interest Expense | $5.4M | +0.0% |
| Pre-tax Income | -$73.8M | -2605.5% |
| Income Tax | $9K | — |
| Net Income | -$73.8M | -2606.0% |
| EPS (Basic) | -$4.00 | -105.1% |
| EPS (Diluted) | -$4.00 | -105.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Short-term Investments | $3.7M | +980.9% |
| Accounts Receivable | $52K | -73.4% |
| Current Assets | $121.9M | +3623.0% |
| Total Assets | $307.4M | +6925.3% |
| Current Liabilities | $80.8M | — |
| Long-term Debt | $127.4M | — |
| Total Liabilities | $208.1M | — |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.0M | -643.0% |
| Capital Expenditures | $2K | -89.9% |
| Investing Cash Flow | -$221.5M | — |
| Financing Cash Flow | $242.9M | — |
| Free Cash Flow | -$18.0M | -637.0% |
| $99.3M |
| +2734.5% |